These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 16737818)
1. Regiocontrolled synthesis and HIV inhibitory activity of unsymmetrical binaphthoquinone and trimeric naphthoquinone derivatives of conocurvone. Stagliano KW; Emadi A; Lu Z; Malinakova HC; Twenter B; Yu M; Holland LE; Rom AM; Harwood JS; Amin R; Johnson AA; Pommier Y Bioorg Med Chem; 2006 Aug; 14(16):5651-65. PubMed ID: 16737818 [TBL] [Abstract][Full Text] [Related]
2. Antiviral agents 2. Synthesis of trimeric naphthoquinone analogues of conocurvone and their antiviral evaluation against HIV. Crosby IT; Bourke DG; Jones ED; de Bruyn PJ; Rhodes D; Vandegraaff N; Cox S; Coates JA; Robertson AD Bioorg Med Chem; 2010 Sep; 18(17):6442-50. PubMed ID: 20685126 [TBL] [Abstract][Full Text] [Related]
3. Regiocontrolled synthesis of the trimeric quinone framework of conocurvone. Emadi A; Harwood JS; Kohanim S; Stagliano KW Org Lett; 2002 Feb; 4(4):521-4. PubMed ID: 11843581 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation and molecular modeling studies of quinolonyl diketo acid derivatives: new structural insight into the HIV-1 integrase inhibition. Vandurm P; Guiguen A; Cauvin C; Georges B; Le Van K; Michaux C; Cardona C; Mbemba G; Mouscadet JF; Hevesi L; Van Lint C; Wouters J Eur J Med Chem; 2011 May; 46(5):1749-56. PubMed ID: 21385662 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of HQCAs with aryl or benzyl substituents on N-1 position as potential HIV-1 integrase inhibitors. He QQ; Zhang X; Wu HQ; Gu SX; Ma XD; Yang LM; Zheng YT; Chen FE Bioorg Med Chem; 2011 Sep; 19(18):5553-8. PubMed ID: 21862337 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, antiviral, and anti-HIV-1 integrase activities of 3-aroyl-1,1-dioxo-1,4,2-benzodithiazines. Brzozowski Z; Saczewski F; Sanchez T; Kuo CL; Gdaniec M; Neamati N Bioorg Med Chem; 2004 Jul; 12(13):3663-72. PubMed ID: 15186851 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of 5-fluoroquinolone-3-carboxylic acids as potential HIV-1 integrase inhibitors. He QQ; Zhang X; Yang LM; Zheng YT; Chen F J Enzyme Inhib Med Chem; 2013 Aug; 28(4):671-6. PubMed ID: 22468749 [TBL] [Abstract][Full Text] [Related]
8. Chemistry and structure-activity relationship of HIV-1 integrase inhibitor integracide B and related natural products. Singh SB; Ondeyka JG; Schleif WA; Felock P; Hazuda DJ J Nat Prod; 2003 Oct; 66(10):1338-44. PubMed ID: 14575434 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of derivatives of the marine quinone avarone. Bozić T; Novaković I; Gasić MJ; Juranić Z; Stanojković T; Tufegdzić S; Kljajić Z; Sladić D Eur J Med Chem; 2010 Mar; 45(3):923-9. PubMed ID: 19995673 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of 5-(1-H or 1-alkyl-5-oxopyrrolidin-3-yl)-8-hydroxy-[1,6]-naphthyridine-7-carboxamide inhibitors of HIV-1 integrase. Melamed JY; Egbertson MS; Varga S; Vacca JP; Moyer G; Gabryelski L; Felock PJ; Stillmock KA; Witmer MV; Schleif W; Hazuda DJ; Leonard Y; Jin L; Ellis JD; Young SD Bioorg Med Chem Lett; 2008 Oct; 18(19):5307-10. PubMed ID: 18774711 [TBL] [Abstract][Full Text] [Related]
12. Diketoacid chelating ligands as dual inhibitors of HIV-1 integration process. Rogolino D; Carcelli M; Compari C; De Luca L; Ferro S; Fisicaro E; Rispoli G; Neamati N; Debyser Z; Christ F; Chimirri A Eur J Med Chem; 2014 May; 78():425-30. PubMed ID: 24704615 [TBL] [Abstract][Full Text] [Related]
13. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores. Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623 [TBL] [Abstract][Full Text] [Related]
15. New HIV-1 replication inhibitors of the styryquinoline class bearing aroyl/acyl groups at the C-7 position: synthesis and biological activity. Normand-Bayle M; Bénard C; Zouhiri F; Mouscadet JF; Leh H; Thomas CM; Mbemba G; Desmaële D; d'Angelo J Bioorg Med Chem Lett; 2005 Sep; 15(18):4019-22. PubMed ID: 16002283 [TBL] [Abstract][Full Text] [Related]
16. Symmetrical 1-pyrrolidineacetamide showing anti-HIV activity through a new binding site on HIV-1 integrase. Du L; Zhao YX; Yang LM; Zheng YT; Tang Y; Shen X; Jiang HL Acta Pharmacol Sin; 2008 Oct; 29(10):1261-7. PubMed ID: 18817633 [TBL] [Abstract][Full Text] [Related]
17. Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease. Mazumder A; Wang S; Neamati N; Nicklaus M; Sunder S; Chen J; Milne GW; Rice WG; Burke TR; Pommier Y J Med Chem; 1996 Jun; 39(13):2472-81. PubMed ID: 8691444 [TBL] [Abstract][Full Text] [Related]
18. Pharmacophore and structure-activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase. Wang Z; Tang J; Salomon CE; Dreis CD; Vince R Bioorg Med Chem; 2010 Jun; 18(12):4202-11. PubMed ID: 20576573 [TBL] [Abstract][Full Text] [Related]
19. Styrylquinoline derivatives: a new class of potent HIV-1 integrase inhibitors that block HIV-1 replication in CEM cells. Mekouar K; Mouscadet JF; Desmaële D; Subra F; Leh H; Savouré D; Auclair C; d'Angelo J J Med Chem; 1998 Jul; 41(15):2846-57. PubMed ID: 9667973 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel antiviral agents as protein-protein interaction inhibitors. Ferro S; De Luca L; Morreale F; Christ F; Debyser Z; Gitto R; Chimirri A J Enzyme Inhib Med Chem; 2014 Apr; 29(2):237-42. PubMed ID: 23859152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]